02.01.2015 Views

Cell Biology Annual Report 2010-11 (FY 2011) - Department of Cell ...

Cell Biology Annual Report 2010-11 (FY 2011) - Department of Cell ...

Cell Biology Annual Report 2010-11 (FY 2011) - Department of Cell ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

CBP Faculty Research Summaries<br />

<strong>Cell</strong> <strong>Biology</strong> and Physiology<br />

<strong>Annual</strong> <strong>Report</strong><br />

Raymond A. Frizzell, Ph.D.<br />

Pr<strong>of</strong>essor<br />

Director <strong>of</strong> Cystic Fibrosis Research Center<br />

Dr. Frizzell’s interests concern the mechanisms <strong>of</strong> salt and water transport in secretory and<br />

absorptive epithelia and pathways that regulate these processes. Specifically, we are defining<br />

defects in ion transport regulation in the genetic disease, cystic fibrosis (CF), membrane<br />

trafficking <strong>of</strong> wild-type and mutant ion channel proteins, gene expression and therapeutic<br />

strategies. Since most CF is caused by the cellular destruction <strong>of</strong> misfolded mutant CF<br />

proteins, our main research efforts focus on defining the steps in the biogenesis <strong>of</strong> the CF protein<br />

(CFTR), and the quality control checkpoints where mutant CFTR proteins go ‘<strong>of</strong>f-pathway’ and<br />

are degraded by the proteasome. CFTR processing can be viewed as a ‘bucket brigade’ in which<br />

protein is passed from checkpoint to checkpoint and some is lost at each step. Therefore, it is<br />

important to know quantitatively the contribution <strong>of</strong> each step to the loss <strong>of</strong> CFTR protein so<br />

that the major one(s) can be targeted for drug development. Recently, we have described novel<br />

interactions <strong>of</strong> CFTR with chaperones called small heat shock proteins, which we have found to<br />

catalyze the addition <strong>of</strong> SUMO, a ubiquitin related modifier, to selectively target mutant CFTR<br />

for degradation. The selectivity <strong>of</strong> this pathway for mutant CFTR appears to extend also to<br />

misfolded proteins that lead also to neurodegenerative diseases, and the results implicate the<br />

components <strong>of</strong> this pathway as therapeutic targets for correcting mutant protein biogenesis.<br />

Finally, we have identified an alternative anion channel at the apical membranes <strong>of</strong> airway<br />

epithelial cells, and we are examining its contribution to salt and water secretion in the<br />

formation <strong>of</strong> airway surface liquid. This channel interacts tightly with CFTR, regulates its<br />

activity, and their interaction influences the biogenesis <strong>of</strong> both proteins. The activation <strong>of</strong> this<br />

channel could provide an alternative to CFTR for regulation <strong>of</strong> airway liquid properties.<br />

We also study the regulation <strong>of</strong> epithelial sodium transport in airway epithelia and the distal<br />

nephron <strong>of</strong> the kidney. Our interests lie in identifying the factors that control the apical<br />

membrane density <strong>of</strong> the sodium entry channel, ENaC, and how the mechanisms <strong>of</strong> apical<br />

insertion, retrieval and recycling influence sodium absorption. The role <strong>of</strong> 14-3-3 protein<br />

binding is a current interest in the regulation <strong>of</strong> both CFTR and ENaC trafficking, and 14-3-3<br />

affinity capture methods are being used to identify new traffic proteins that are phosphorylated<br />

by regulators such as aldosterone and vasopressin. Defects in these processes influence the<br />

severity <strong>of</strong> both cystic fibrosis and hypertension.<br />

Vernon L. Gay, Ph.D.<br />

Associate Pr<strong>of</strong>essor<br />

Dr. Gay began his training in reproductive endocrinology as a graduate student at Indiana<br />

University in Bloomington. While there he devised a technique for rapid transauricular<br />

hypophysectomy <strong>of</strong> rats and used available bioassays to obtain the first measurements <strong>of</strong> the half<br />

lives <strong>of</strong> endogenous LH and FSH in the rat.<br />

24<br />

For his post-doctoral work Dr. Gay moved to the University <strong>of</strong> Michigan in Ann Arbor at a time<br />

when radio-immunoassays for gonadotropins (LH and FSH) were first available. In addition<br />

to describing hormone pr<strong>of</strong>iles throughout the reproductive cycle <strong>of</strong> the female rat, he was one<br />

<strong>of</strong> the first to describe the phenomenon <strong>of</strong> pulsatile pituitary hormone secretion in any species<br />

(specifically the castrated rat).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!